Evidence map›Paper›PMID 26622186›Full record

ArticleClinicoEconomics and outcomes research : CEOR2015

The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria.

Oladele Simeon Olatunya, Ezra Olatunde Ogundare, Joseph Olusesan Fadare, Isaac Oludare Oluwayemi, Oyinkansola Tolulope Agaja, Babajide Samson Adeyefa, Odunayo Aderiye

Abstract read
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oladele Simeon OlatunyaDepartment of Paediatrics, Ekiti State University, Ado Ekiti, Nigeria ; Department of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.
Ezra Olatunde OgundareDepartment of Paediatrics, Ekiti State University, Ado Ekiti, Nigeria ; Department of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.
Joseph Olusesan FadareDepartment of Clinical Pharmacology, Ekiti State University, Ado Ekiti, Nigeria.
Isaac Oludare OluwayemiDepartment of Paediatrics, Ekiti State University, Ado Ekiti, Nigeria ; Department of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.
Oyinkansola Tolulope AgajaDepartment of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.
Babajide Samson AdeyefaDepartment of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.
Odunayo AderiyeDepartment of Paediatrics, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies on economic impact of sickle cell disease (SCD) are scanty despite its being common among children in developing countries who are mostly Africans.

objectiveTo determine the financial burden of SCD on households in Ado Ekiti, Southwest Nigeria.

methodsA longitudinal and descriptive study of household expenditures on care of 111 children with SCD managed at the pediatric hematology unit of the Ekiti State University Teaching Hospital was conducted between January and December 2014.

resultsThere were 64 male and 47 female children involved, aged between 15 and 180 months. They were from 111 households, out of which only eight (7.2%) were enrolled under the National Health Insurance Scheme. The number of admissions and outpatients' consultations ranged from 1 to 5 and 1 to 10 per child, respectively. Malaria, vaso-occlusive crisis, and severe anemia were the leading comorbidities. The monthly household income ranged between ₦12,500 and ₦330,000 (US$76 and US$2,000) with a median of ₦55,000 (US$333), and health expenditure ranged between ₦2,500 and ₦215,000 (US$15 and US$1,303) with a mean of ₦39,554±35,479 (US$240±215). Parents of 63 children lost between 1 and 48 working days due to their children's ill health. Parents of 23 children took loans ranging between ₦6,500 and ₦150,000 (US$39 and US$909) to offset hospital bills. The percentage of family income spent as health expenditure on each child ranged from 0.38 to 34.4. Catastrophic health expenditure (when the health expenditure >10% of family income) occurred in 23 (20.7%) households. Parents who took loan to offset hospital bills, low social class, and patients who took ill during the study period significantly had higher odds for catastrophic health expenditure (95% confidence interval [CI] 5.399-87.176, P=0.000; 95% CI 2.322-47.310, P=0.002; and 95% CI 1.128-29.694, P=0.035, respectively).

conclusionSCD poses enormous financial burden on parents and households.

Indexed as

family incomefinancial catastrophehealth expenditureNigeriasickle cell disease

Identifiers

PMID26622186
PMCPMC4639479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.